Fmr LLC Sage Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 4,133 shares of SAGE stock, worth $35,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,133

Previous 8,263 49.98%

Holding current value

$35,874

Previous $65,000 43.08%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.38 - $9.3 $26,349 - $38,409	-4,130 Reduced 49.98%	4,133 $37,000
Q1 2025 May 12, 2025	SELL	$5.55 - $8.66 $22.8 Million - $35.6 Million	-4,108,743 Reduced 99.8%	8,263 $65,000
Q4 2024 Feb 13, 2025	SELL	$4.78 - $8.57 $5.52 Million - $9.89 Million	-1,154,102 Reduced 21.89%	4,117,006 $22.4 Million
Q3 2024 Nov 13, 2024	SELL	$7.02 - $13.08 $3.88 Million - $7.22 Million	-552,248 Reduced 9.48%	5,271,108 $38 Million
Q2 2024 Aug 13, 2024	SELL	$10.58 - $17.9 $475,327 - $804,193	-44,927 Reduced 0.77%	5,823,356 $63.2 Million
Q1 2024 May 13, 2024	BUY	$18.62 - $26.95 $7.18 Million - $10.4 Million	385,806 Added 7.04%	5,868,283 $110 Million
Q4 2023 Feb 13, 2024	SELL	$17.1 - $22.26 $37.9 Million - $49.3 Million	-2,213,578 Reduced 28.76%	5,482,477 $119 Million
Q3 2023 Nov 13, 2023	SELL	$16.75 - $48.98 $18.3 Million - $53.6 Million	-1,093,682 Reduced 12.44%	7,696,055 $158 Million
Q2 2023 Aug 11, 2023	BUY	$40.65 - $59.54 $69.4 Million - $102 Million	1,706,204 Added 24.09%	8,789,737 $413 Million
Q1 2023 May 11, 2023	BUY	$37.27 - $46.57 $19.8 Million - $24.8 Million	532,042 Added 8.12%	7,083,533 $297 Million
Q4 2022 Feb 13, 2023	BUY	$32.2 - $43.61 $7.53 Million - $10.2 Million	233,957 Added 3.7%	6,551,491 $250 Million
Q3 2022 Nov 10, 2022	BUY	$32.28 - $43.27 $11 Million - $14.7 Million	340,441 Added 5.7%	6,317,534 $247 Million
Q2 2022 Aug 12, 2022	BUY	$27.52 - $37.99 $9.51 Million - $13.1 Million	345,568 Added 6.14%	5,977,093 $193 Million
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $4.33 Million - $6.44 Million	140,951 Added 2.57%	5,631,525 $186 Million
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $5.43 Million - $6.9 Million	-146,510 Reduced 2.6%	5,490,574 $234 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $49.3 Million - $70.3 Million	-1,224,575 Reduced 17.85%	5,637,084 $250 Million
Q2 2021 Aug 13, 2021	BUY	$54.88 - $79.29 $377 Million - $544 Million	6,861,659 New	6,861,659 $390 Million

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

50.2M

Call Options Held

790K

Put Options Held

440K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $516M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account